Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients.

Jensen JE, Daniels M, Haws C, Bolo NR, Lyoo IK, Yoon SJ, Cohen BM, Stoll AL, Rusche JR, Renshaw PF. Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Exp Clin Psychopharmacol. 2008 Jun; 16(3):199-206.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.